Tag: Pharmaceuticals

Japan emerges as a hub for regenerative medicine, with opportunities for foreign companies amid strict local regulations

UK-based Rouse boosts regional presence with Wrays, a 100-year-old IP firm in Australia and New Zealand

Jiangsu Hengrui and GSK reached a USD12.5bn deal, with Cooley, Davis Polk and Han Kun advising

The India-UAE CEPA has set a benchmark for modern trade agreements, yielding benefits in many sectors

India’s outdated product testing rules raise compliance costs and delay market access, calling for urgent reform and global alignment

India attracted USD165.1 billion in FDI to manufacturing over 10 years, boosted by Make in India and related reforms

China issues record pharma fine, targeting firms and individual for monopoly violations

Shujath Bin Ali becomes chief legal officer at Fourth Partner Energy, a top renewable energy platform in India      

Akshay Kishore has joined Duane Morris & Selvam as a director while Mark Ng will be joining him as a senior associate

Isshiki & Partners has strengthened its IP practice with the partner hire of Hiromi Furushima

Hengrui raises HKD9.8bn in Hong Kong's largest pharma IPO in five years

Japan’s pharma market demands careful regulatory and approval transfer compliance

Nagashima Ohno advises JT’s Torii on JPY160b takeover bid by Shionogi, which is counselled by Nishimura & Asahi

Japan is easing restrictions on medical data under two key laws as it focuses on promoting the use of this information

Wong & Partners has hired Celia Cheah as IP partner; she brings 20+ years of expertise from Christopher & Lee Ong

The life sciences sector in Russia stays stable with local production incentives and EEU regulatory unity

AZB & Partners and Tempus Law Associates advised on PAG’s USD200 million majority stake acquisition in Pravesha Industries

South Korea boosts drug development; Russia tackles telemedicine and data protection

Section 3(b) of the Indian Patents Act, 1970, bars patents for inventions contrary to morality or harmful to life

In Zuventus Healthcare Limited v Zaventis Health Care Private Limited, the plaintiff sought an urgent permanent injunction from Delhi High Court without notifying the defendant

Skadden and Latham & Watkins are advising Otsuka Pharmaceutical on its USD1.12 billion acquisition of Jnana Therapeutics

Simpson Thacher & Bartlett and Nishimura & Asahi are advising on the USD2.1 billion acquisition of Alinamin

A comparison of evolving legal frameworks that are helping to shape the massive life sciences industries in China and India

China’s 2021 Patent Law overhauled life sciences protection with US-style patent linkage, term extension (PTE), and term adjustment (PTA)

India's life sciences laws regulate medicines, devices, biotech, and healthcare, ensuring quality, efficacy, safety, and consumer protection

Goodwin Procter and Greenberg Traurig have assisted on a USD2.4 billion merger between American biotechnology enterprise Deciphera with ONO

Amid the cool capital markets climate, the recent surge in billion-dollar M&A deals involving overseas biomedical companies

Kirkland & Ellis, Clifford Chance, Sullivan & Cromwell and Slaughter and May advise on Silver Pegasus Investment's HKD8.79 billion take-private of SciClone Pharmaceuticals in Hong Kong

Trilegal advised JB Pharmaceuticals in its acquisition of a portfolio of specific ophthalmology brands from Novartis for INR10.9 billion

Drug pricing and reimbursement top the agenda in South Korea, while Japan is exploring the impact of digital technology on medical information

Gibson Dunn, Orrick, and DeHeng facilitate BJContinent's historic reverse US takeover under new rule

Dentons welcomes partner Timothy Bickham to the Washington DC Office, who will also be head of Dentons China’s IP litigation team to improve the firm’s patent litigation services

JSA advised Torreya Holdings in the 100% acquisition of Torreya Partners by Stifel Financial Corp for an undisclosed amount

Volume-based procurement (VBP) of drugs and medical supplies has become the new normal in China’s medical sector

Khaitan & Co assisted Eris Oaknet Healthcare in a USD42 million deal to acquire nine dermatology trademarks from Glenmark Pharmaceuticals

Fangda Partners has hired Shanghai-based Henry He and Guangzhou-based Judy Tan as partners to grow the firm’s biopharmaceutical and aircraft leasing business

In this article, they explain from first-hand experience major legal and compliance risks for healthcare companies operating in Japan